Advertisement
Home 2015

Archives

The U.S. Preventive Services Task Force has concluded that the benefits and harms of low-dose aspirin for prevention of cardiovascular disease and cancer vary by patient age. These findings form the basis of a draft recommendation statement published online Sept. 14 by the USPSTF.

USPSTF Recommendations for Aspirin Use Vary by Age

0
Recommended for some patients aged 50 to 59 years; insufficient evidence for those <50, ≥70
Clinicians should control hypertension much more aggressively than current guidelines suggest

NIH: Benefits for More Intensive Control of Hypertension

0
Rates of heart attack, heart failure, and stroke cut significantly by more aggressive treatment
Physician access for pharmaceutical representatives is continuing to decline

For Pharma Reps, Access to Physicians Continuing to Drop

0
Only 47 percent of prescribers considered accessible in 2015, compared with 55 percent in 2013
The percentage of youth ages 12 to 17 who smoke

Rates of Alcohol, Tobacco Use Down Among U.S. Teens

0
But marijuana, heroin use up
The California State Assembly approved a bill on Wednesday that would allow doctors to prescribe life-ending medications to patients expected to die within six months.

California State Assembly Approves Right-to-Die Bill

0
California would become fifth state in which people are allowed to legally end their lives
The U.S. Food and Drug Administration announced new steps Thursday to improve the cleanliness of food manufacturing plants in the wake of a string of foodborne illness outbreaks.

FDA Announces New Steps to Improve Food Safety in U.S.

0
New rules focus on cleanliness of manufacturing facilities
A second death has been reported in a Salmonella outbreak that has been linked to contaminated cucumbers and caused 341 illnesses in 30 states

CDC: Second Death Reported in Salmonella Outbreak

0
Tainted cucumbers also linked to 341 illnesses in 30 states, CDC officials report
Two newly approved medications to treat high cholesterol are extremely overpriced compared to the health benefits they give to patients

ICER: New Cholesterol Drugs Highly Overpriced

0
Newly FDA-approved Repatha and Praluent currently cost more than $14,000 per year
The U.S. Preventive Services Task Force (USPSTF) recommends screening for major depressive disorder in adolescents

USPSTF Recommends Depression Screening for Teens

0
Screening advised for those aged 12-18; insufficient evidence to weigh benefits for younger children
The U.S. Food and Drug Administration has issued a warning that injectable skin-lightening products are potentially unsafe and ineffective.

FDA Issues Warning Regarding Injectable Skin Lighteners

0
Injectable products may contain unknown substances or contaminants